25.National Institute for Health and Clinical Excellence. Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes London: NICE, 2009.26.Holman RR, Thorne KI, Farmer AJ, et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med2007;357:1716-30.28.Diabetes UK. Recommendations for the management of diabetes in primary care

1.United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
2.National Institute for Health and Clinical Excellence. Type 2 Diabetes. National clinical guideline for management in primary and secondary care (update) London: NICE, 2008.
3.Williams B, Poulter NR, Brown MJ, Davis M, et al

Литература
1. Diabetes UK. Recommendations for the management of diabetes in primary care. London: Diabetes UK, 2000.
2. The Information Centre, Information and Statistical Governance, Department of Health 2008